Trial Profile
A Multicenter Randomized Trial Evaluating the Efficacy of Sarpogrelate on Ischemic Heart Disease After Drug-eluting Stent Implantation in Patients With Diabetes Mellitus or Renal Impairment
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Jun 2016
Price :
$35
*
At a glance
- Drugs Sarpogrelate (Primary) ; Aspirin; Clopidogrel
- Indications Coronary artery disease
- Focus Registrational; Therapeutic Use
- Acronyms SERENADE
- 01 Jul 2015 Trial design presented at Contemporary Clinical Trials
- 22 Nov 2014 New trial record